Differences in MicroRNA Expression in Pericoronary Adipose Tissue in Coronary Artery Disease Compared to Severe Valve

Maria Marketou1, Joanna Kontaraki2, Paris Kalogerakos3

  • 1Cardiology Department, Heraklion University General Hospital, Crete, Greece.

Angiology
|October 10, 2022
PubMed

Insights

Pericoronary adipose tissue (PCAT) near coronary lesions shows altered microRNA (miR) expression in patients with coronary artery disease (CAD). This suggests PCAT plays a role in atherosclerosis development.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Atherosclerosis Research

Background:

  • Pericoronary adipose tissue (PCAT) mediates intercellular communication via microRNAs (miRs).
  • Specific miR expression patterns in PCAT adjacent to atherosclerotic lesions are not well understood.

Purpose of the Study:

  • To investigate differential miR expression in PCAT from atherosclerotic versus plaque-free coronary segments.
  • To compare miR expression in PCAT between patients with and without coronary artery disease (CAD).

Main Methods:

  • PCAT was harvested from two sites in patients undergoing cardiac surgery: adjacent to significant lesions and from plaque-free segments.
  • Quantitative real-time reverse transcription polymerase chain reaction (RT-PCR) was used to measure levels of specific miRs (miR-133a, miR-21, miR-26b, miR-9, miR-143).

Main Results:

  • Patients with CAD exhibited significantly lower expression of miR-133, miR-21, and miR-26b in plaque-free PCAT compared to controls.
  • In CAD patients, PCAT from atherosclerotic lesions showed significantly higher expression of miR-133, miR-21, and miR-143 compared to plaque-free segments.

Conclusions:

  • PCAT exhibits distinct miR expression profiles in the presence of coronary atherosclerosis.
  • These findings highlight a potential role for PCAT-derived miRs in the pathophysiology of atherosclerosis.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
24
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
25
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37